Vivos (RDGL) Net Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.13% |
| Sep 30, 2025 | -14.41% |
| Jun 30, 2025 | -34.97% |
| Mar 31, 2025 | 134.19% |
| Dec 31, 2024 | 55.86% |
| Sep 30, 2024 | -39.98% |
| Jun 30, 2024 | 66.05% |
| Mar 31, 2024 | -51.95% |
| Dec 31, 2023 | 58.78% |
| Jun 30, 2023 | -622.20% |
| Mar 31, 2023 | -104.05% |
| Dec 31, 2022 | -82.82% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | -20.06% |
| Mar 31, 2022 | -146.89% |
| Dec 31, 2021 | 34.94% |
| Sep 30, 2021 | -15.48% |
| Jun 30, 2021 | -6.98% |
| Mar 31, 2021 | 87.77% |
| Dec 31, 2020 | 38.94% |
| Sep 30, 2020 | -65.51% |
| Jun 30, 2020 | 59.33% |
| Mar 31, 2020 | -54.27% |
| Dec 31, 2019 | -236.13% |
| Sep 30, 2019 | 26.22% |
| Jun 30, 2019 | -24.50% |
| Mar 31, 2019 | -16.91% |
| Dec 31, 2018 | 17.18% |
| Jun 30, 2018 | 80.75% |
| Mar 31, 2018 | -16.39% |
| Dec 31, 2017 | 19.57% |
| Sep 30, 2017 | -65.34% |
| Jun 30, 2017 | 262.42% |
| Mar 31, 2017 | 36.08% |
| Dec 31, 2016 | -150.31% |
| Sep 30, 2016 | 200.11% |
| Jun 30, 2016 | -14.16% |
| Mar 31, 2016 | 16.55% |
| Dec 31, 2015 | 15.96% |
| Sep 30, 2015 | -15.30% |